Guangzhou Kingmed Diagnostics Group Co Ltd
Guangzhou Kingmed Diagnostics Group Co., Ltd. provides medical diagnosis services in China. It also provides health check-up, cold chain logistics, and other services. Guangzhou Kingmed Diagnostics Group Co., Ltd. was founded in 2006 and is headquartered in Guangzhou, China.
Market Cap & Net Worth: Guangzhou Kingmed Diagnostics Group Co Ltd (603882)
Guangzhou Kingmed Diagnostics Group Co Ltd (SHG:603882) has a market capitalization of $1.76 Billion (CN¥12.93 Billion) as of March 18, 2026. Listed on the SHG stock exchange, this China-based company holds position #6921 globally and #1124 in its home market, demonstrating a -1.03% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Guangzhou Kingmed Diagnostics Group Co Ltd's stock price CN¥27.91 by its total outstanding shares 463258275 (463.26 Million).
Guangzhou Kingmed Diagnostics Group Co Ltd Market Cap History: 2017 to 2026
Guangzhou Kingmed Diagnostics Group Co Ltd's market capitalization history from 2017 to 2026. Data shows growth from $1.90 Billion to $1.76 Billion (13.50% CAGR).
Guangzhou Kingmed Diagnostics Group Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Guangzhou Kingmed Diagnostics Group Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.24x
Guangzhou Kingmed Diagnostics Group Co Ltd's market cap is 0.24 times its annual revenue
0.68x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $1.90 Billion | $3.79 Billion | $188.51 Million | 0.50x | 10.08x |
| 2018 | $1.34 Billion | $4.53 Billion | $233.32 Million | 0.30x | 5.75x |
| 2019 | $3.10 Billion | $5.27 Billion | $402.33 Million | 0.59x | 7.69x |
| 2020 | $7.75 Billion | $8.24 Billion | $1.51 Billion | 0.94x | 5.14x |
| 2021 | $6.76 Billion | $11.94 Billion | $2.22 Billion | 0.57x | 3.04x |
| 2022 | $4.82 Billion | $15.48 Billion | $2.75 Billion | 0.31x | 1.75x |
| 2023 | $3.95 Billion | $8.54 Billion | $643.38 Million | 0.46x | 6.14x |
| 2024 | $1.74 Billion | $7.19 Billion | -$381.24 Million | 0.24x | N/A |
Competitor Companies of 603882 by Market Capitalization
Companies near Guangzhou Kingmed Diagnostics Group Co Ltd in the global market cap rankings as of March 18, 2026.
Key companies related to Guangzhou Kingmed Diagnostics Group Co Ltd by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #91 globally with a market cap of $176.18 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #154 globally with a market cap of $120.38 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #466 globally with a market cap of $46.34 Billion USD.
- Lonza Group Ltd (PINK:LZAGF): Ranked #512 globally with a market cap of $41.73 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #91 | Thermo Fisher Scientific Inc | NYSE:TMO | $176.18 Billion | $470.00 |
| #154 | Danaher Corporation | NYSE:DHR | $120.38 Billion | $191.39 |
| #466 | IDEXX Laboratories Inc | NASDAQ:IDXX | $46.34 Billion | $586.37 |
| #512 | Lonza Group Ltd | PINK:LZAGF | $41.73 Billion | $596.13 |
Guangzhou Kingmed Diagnostics Group Co Ltd Historical Marketcap From 2017 to 2026
Between 2017 and today, Guangzhou Kingmed Diagnostics Group Co Ltd's market cap moved from $1.90 Billion to $ 1.76 Billion, with a yearly change of 13.50%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥1.76 Billion | -1.59% |
| 2025 | CN¥1.79 Billion | +3.01% |
| 2024 | CN¥1.74 Billion | -56.00% |
| 2023 | CN¥3.95 Billion | -17.98% |
| 2022 | CN¥4.82 Billion | -28.70% |
| 2021 | CN¥6.76 Billion | -12.87% |
| 2020 | CN¥7.75 Billion | +150.52% |
| 2019 | CN¥3.10 Billion | +130.54% |
| 2018 | CN¥1.34 Billion | -29.33% |
| 2017 | CN¥1.90 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Guangzhou Kingmed Diagnostics Group Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.76 Billion USD |
| MoneyControl | $1.76 Billion USD |
| MarketWatch | $1.76 Billion USD |
| marketcap.company | $1.76 Billion USD |
| Reuters | $1.76 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.